Page last updated: 2024-10-18

dihydroxyphenylalanine and Erdheim-Chester Disease

dihydroxyphenylalanine has been researched along with Erdheim-Chester Disease in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Erdheim-Chester Disease: A rare form of non-Langerhans-cell histiocytosis (HISTIOCYTOSIS, NON-LANGERHANS-CELL) with onset in middle age. The systemic disease is characterized by infiltration of lipid-laden macrophages, multinucleated giant cells, an inflammatory infiltrate of lymphocytes and histiocytes in the bone marrow, and a generalized sclerosis of the long bones.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
García-Gómez, FJ1
Acevedo-Báñez, I1
Martínez-Castillo, R1
Tirado-Hospital, JL1
Cuenca-Cuenca, JI1
Pachón-Garrudo, VM1
Álvarez-Pérez, RM1
García-Jiménez, R1
Rivas-Infante, E1
García-Morillo, JS1
Borrego-Dorado, I1

Other Studies

1 other study available for dihydroxyphenylalanine and Erdheim-Chester Disease

ArticleYear
The role of 18FDG, 18FDOPA PET/CT and 99mTc bone scintigraphy imaging in Erdheim-Chester disease.
    European journal of radiology, 2015, Volume: 84, Issue:8

    Topics: Adult; Aged; Bone and Bones; Dihydroxyphenylalanine; Erdheim-Chester Disease; Female; Fluorodeoxyglu

2015